Sphera Funds Management Ltd. Uni Qure N.V. Transaction History

Sphera Funds Management Ltd.

$683 Million
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $964,482 - $1.93 Million	86,734 Added 139.89%	148,734 $1.7 Million
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $1.16 Million - $1.43 Million	62,000 New	62,000 $1.25 Million
Q2 2021 Aug 17, 2021	BUY	$29.97 - $37.17 $5.15 Million - $6.39 Million	172,000 New	172,000 $5.3 Million
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $6.32 Million - $9.08 Million	-216,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $3.18 Million - $4.56 Million	90,000 Added 71.43%	216,000 $7.8 Million
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $575,680 - $762,560	16,000 Added 14.55%	126,000 $4.64 Million
Q2 2020 Aug 13, 2020	SELL	$45.06 - $67.74 $4.11 Million - $6.17 Million	-91,107 Reduced 45.3%	110,000 $4.96 Million
Q1 2020 May 14, 2020	BUY	$40.01 - $73.97 $2.46 Million - $4.56 Million	61,593 Added 44.15%	201,107 $9.54 Million
Q4 2019 Feb 13, 2020	SELL	$37.13 - $74.62 $1.41 Million - $2.83 Million	-37,986 Reduced 21.4%	139,514 $10 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $4.62 Million - $9.01 Million	117,351 Added 195.1%	177,500 $6.99 Million
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $907,472 - $1.41 Million	-17,200 Reduced 22.24%	60,149 $0
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $4.26 Million - $10.6 Million	-155,500 Reduced 66.78%	77,349 $4.61 Million
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $1.25 Million - $1.87 Million	55,000 Added 30.93%	232,849 $6.71 Million
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $754,430 - $1.09 Million	25,359 Added 16.63%	177,849 $6.47 Million
Q2 2018 Aug 13, 2018	BUY	$21.96 - $39.94 $546,584 - $994,106	24,890 Added 19.51%	152,490 $5.76 Million
Q1 2018 May 10, 2018	BUY	$17.1 - $26.61 $2.18 Million - $3.4 Million	127,600 New	127,600 $3 Million

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account